Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/1998
11/04/1998EP0874829A1 Amino acid derivatives, the preparation and use thereof as endothelin antagonists
11/04/1998EP0874812A1 Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof
11/04/1998CN1198096A C-proteinase inhibitor for treatment of disorders related to overproduction of collagen
11/03/1998US5830887 Cancer, pms, menopause and hypercholesterolemia
11/03/1998US5830886 Steroid sulphatase inhibitors
11/03/1998US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
10/1998
10/29/1998WO1998047882A1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
10/29/1998WO1998047517A1 Stabilized tibolone compositions
10/29/1998WO1998041538A3 Novel human cytokine/steroid receptor protein
10/29/1998CA2288070A1 Stabilized tibolone compositions
10/29/1998CA2285664A1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
10/28/1998EP0873992A1 Indene compounds having activity as SERMs
10/28/1998EP0873751A2 Pharmaceutical product for application to uterus mucosa
10/28/1998EP0873361A2 Nuclear receptor ligands and ligand binding domains
10/28/1998EP0873336A1 Antagonists of gonadotropin releasing hormone
10/28/1998EP0873330A1 Diarylalkenylamine derivatives
10/28/1998EP0873309A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
10/28/1998EP0873295A1 Dimer-selective rxr modulators and methods for their use
10/28/1998EP0605484B1 Peptides having growth hormone releasing activity
10/28/1998CN1040432C Spiro piperdines derivatives and its prepn. and applications
10/27/1998US5827834 Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
10/27/1998CA2063721C Mycobacterium chelonae polar glycopeptidolipids-based immune booster medication
10/22/1998WO1998046748A1 Therapeutic compositions and diagnostic assays for diseases involving trbp
10/22/1998WO1998046634A1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6
10/21/1998EP0871669A1 Human somatostatin-like receptor
10/21/1998EP0871624A1 Antagonists of gonadotropin releasing hormone
10/21/1998EP0871467A1 Novel formulation for peptide release
10/21/1998EP0871463A1 Regulation of eating behavior
10/21/1998EP0871457A1 Isolated stromal cells and methods of using the same
10/21/1998EP0871376A1 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
10/21/1998CN1040329C 15,15-diakyl-substituted derivatives of estradiol
10/20/1998US5824771 Cyclic corticotropin-releasing factor peptides
10/20/1998US5824671 Vaginal atrophy, hypogonadism and loss of collagen or connective tissues
10/20/1998US5824500 Nucleic acid encoding novel human KDEL receptor
10/15/1998WO1998045315A1 Estra-5(10),7-dienes with estrogenic activity
10/15/1998WO1998045288A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators
10/15/1998WO1998045255A1 Calcilytic compounds
10/15/1998WO1998024807A3 Somatostatin antagonists
10/15/1998CA2286457A1 Estra-5(10),7-dienes with estrogenic activity
10/15/1998CA2286454A1 Calcilytic compounds
10/15/1998CA2286204A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators
10/14/1998EP0870039A1 Recombinant fusion proteins to growth hormone and serum albumin
10/14/1998EP0870026A1 Ob protein derivatives having prolonged half-life
10/14/1998EP0869974A1 Compounds with growth hormone releasing properties
10/14/1998EP0869968A1 Growth-hormone secretagogues
10/14/1998EP0869787A1 Vitronectin receptor antagonists
10/14/1998EP0869785A1 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
10/14/1998EP0869782A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
10/14/1998CN1195986A Paroxetine controlled release compositions
10/14/1998CN1195982A Fgfr 3 as marker for mesenchymal skelftal progenitor cells
10/14/1998CN1195666A Intermediates of steroids, their preparation and uses
10/13/1998US5821225 Substituted at position 22-31 of amino acid sequence of a peptide of parathyroid hormone or parathyroid hormone related peptide
10/13/1998US5821123 Modified antibody variable domains
10/07/1998EP0868429A1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/07/1998EP0868178A1 Antagonists of gonadotropin releasing hormone
10/06/1998US5817819 Gonadotropin-releasing hormone antagonist
10/06/1998US5817753 Antigenic modification of polypeptides
10/04/1998CA2233797A1 Pharmaceutical product for application to uterus mucosa
10/01/1998WO1998042749A1 Zinc free insulin crystals for use in pulmonary compositions
10/01/1998WO1998042729A2 Steroid sulfamates, method for the production and use thereof
10/01/1998DE19712488A1 Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben Steroidsulfamate, processes for their preparation and use thereof
10/01/1998CA2283705A1 Zinc free insulin crystals for use in pulmonary compositions
09/1998
09/30/1998EP0866861A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands
09/30/1998EP0866726A1 Pulmonary administration of dry powder alpha 1-antitrypsin
09/30/1998EP0866720A1 Methods of increasing lean tissue mass using ob protein compositions
09/30/1998EP0866656A1 Inhibition of tumor necrosis factor alpha
09/24/1998WO1998041538A2 Novel human cytokine/steroid receptor protein
09/24/1998WO1998041237A1 Preventives and remedies for hyperphosphatemia
09/24/1998CA2284108A1 Novel human cytokine/steroid receptor protein
09/23/1998EP0865426A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds
09/23/1998EP0865425A1 Amino acid derivatives, medicaments containing said compounds and methods of producing them
09/23/1998EP0526658B1 Thiazolidine-2,4-dione derivative, salt thereof, and production of the same
09/22/1998US5811421 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods
09/22/1998US5811410 Nonsteroidal antiinflammatory drugs
09/22/1998US5811249 Control of infectious microorganisms by modulation of chorionic gonadotropin-related protein activity
09/17/1998WO1998039967A1 A method for treating or preventing alzheimer's disease
09/17/1998CA2323889A1 A method for treating or preventing alzheimer's disease
09/16/1998EP0863902A1 2'- 4'-HALO- 1,1'-BIPHENYL]-4-YL]METHYL]-5'-METHYL-SPIRO CYCLOPENTANE-1,7'(8'H)- 3H]IMIDAZO 2,1-b]PURIN]-4'(5'H)-ONES
09/16/1998EP0863754A1 Hydrolysis-optimized lipid emulsions and use thereof
09/16/1998EP0710230B1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
09/16/1998EP0700291B1 15-substituted 4-azasteroids
09/15/1998US5807849 Therapeutic methods and delivery systems utilizing sex steroid precursors
09/15/1998US5807550 Antibodies specifically recognizing somatotropin binding proteins
09/11/1998WO1998039292A1 20-epi-22(r)-lower alkyl-substituted vitamin d derivatives and calcium metabolism improving agents containing the same as the active ingredient
09/09/1998EP0863156A1 Peptides useful as somatostatin antagonists
09/09/1998EP0862644A2 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders
09/09/1998EP0862631A1 Luminal cholecystokinin-releasing factor
09/09/1998EP0862577A2 Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them
09/09/1998EP0862556A1 17-alkyl-7-substituted-4-aza steroid derivatives
09/09/1998EP0862551A1 Fluoro-substituted benzoylpropionic acid derivatives
09/09/1998EP0862436A1 16-substituted-6-aza-steroid 5-alpha-reductase inhibitors
09/09/1998EP0485392B1 Androgen derivatives for use in the inhibition of sex steroid activity
09/09/1998CN1192683A Method for reducing amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
09/08/1998US5804399 Incubation; measuring effect of composition on kinase or polynucleotide encoding the kinase
09/08/1998US5804204 Potassium salts for treatment of hypertension
09/06/1998CA2231012A1 Peptides useful as somatostatin antagonists
09/03/1998WO1998037871A1 Transdermal device for the delivery of testosterone
09/03/1998WO1998016205A3 Stable glassy state powder formulations
09/03/1998WO1998008855A3 N6 heterocyclic substituted adenosine derivatives
09/03/1998CA2281876A1 Transdermal device for the delivery of testosterone
1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 290